Related Experiment Video
Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Managing concomitant cardiac disease and erectile dysfunction
Insights
Sexual activity poses minimal cardiovascular risk, even for patients with a history of myocardial infarction (MI). Guidelines help physicians assess risks for erectile dysfunction (ED) patients with cardiovascular disease (CAD), ensuring safe management.
Area of Science:
- Cardiology
- Sexual Medicine
- Cardiovascular Disease Management
Background:
- Early beliefs suggested sexual activity posed significant cardiovascular risk.
- Subsequent research indicates heart rates during coitus are comparable to physical exercise or anger.
- Coronary artery disease (CAD) is strongly linked to erectile dysfunction (ED), sharing similar risk factors.
Purpose of the Study:
- To re-evaluate the cardiovascular risks associated with sexual activity in patients with cardiovascular disease.
- To assess the safety and efficacy of sildenafil citrate in patients with cardiovascular disease and erectile dysfunction.
- To provide guidance on risk stratification for patients with ED and cardiovascular disease.
Main Methods:
- Review of early and subsequent studies on cardiovascular responses during coitus.
- Analysis of the absolute and relative risk of myocardial infarction (MI) following sexual activity.
- Examination of studies evaluating sildenafil citrate use in patients with cardiovascular disease.
- Reference to clinical guidelines for risk classification of patients with ED and cardiovascular disease.
Main Results:
- The absolute risk of MI during coitus is low (10 per million per hour), with a negligible impact on annual risk even when doubled post-coitus.
- Sildenafil citrate is safe and effective for treating ED in patients with cardiovascular disease, with the sole contraindication being concurrent nitrate use.
- Clinical guidelines allow for risk stratification of patients with ED and cardiovascular disease into low, intermediate, or indeterminate risk categories.
Conclusions:
- Sexual activity is generally safe for most patients with cardiovascular disease.
- Physicians should utilize established guidelines to manage patients with ED and cardiovascular disease, differentiating risk levels.
- Sildenafil can be prescribed cautiously, avoiding concomitant use with nitrates, to manage ED in this population.
Abstract:
Early studies of peak heart rates and blood pressure during coitus led physicians to believe that sexual activity represents a significant risk to patients with cardiovascular disease. Subsequent studies indicated, however, that the heart rate during coitus was no higher than the rate during unaccustomed physical exercise or associated with anger. The absolute risk of myocardial infarction (MI) in a patient with a history of MI has been found to be 10 per million per hour, and the doubling of this risk in the 2 hours following coitus has a negligible impact on annual risk. Coronary artery disease (CAD) is a powerful indicator of the presence of erectile dysfunction (ED), and the risk factors for ED are similar to those for CAD. Studies of sildenafil citrate use in patients with a history of cardiovascular disease have found sildenafil to be safe and effective, except for an absolute contraindication in the concomitant use of nitrates. Physicians should become familiar with the clinical guidelines for classifying ED patients with a history of cardiovascular disease as high risk, intermediate or indeterminate risk, and low risk. The guidelines permit physicians MIlow risk while deferring the resumption of sexual activity among higher risk patients pending further evaluation.
Related Concept Videos
Heart Failure V: Medical Management
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Angina IV: Management
Rheumatic Heart Disease III: Medical Management